SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Miyuki Ono, James M. Ogilvie, Jennifer S. Wilson, Heather J. Green, Suzanne K. Chambers, Tamara Ownsworth, David H. K. Shum, A Meta-Analysis of Cognitive Impairment and Decline Associated with Adjuvant Chemotherapy in Women with Breast Cancer, Frontiers in Oncology, 2015, 5,

    CrossRef

  2. 2
    Yoo Young Hoogendam, Sanne B. Schagen, M. Arfan Ikram, Willem Boogerd, Caroline Seynaeve, Rachael D. Seidler, Monique M. B. Breteler, Jos N. Van der Geest, Vincent Koppelmans, Late effects of adjuvant chemotherapy for breast cancer on fine motor function, Psycho-Oncology, 2015, 24,
  3. 3
    Rex M. Philpot, Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits, Neurochemical Research, 2015,

    CrossRef

  4. 4
    Jin-Hee Park, Sun Hyoung Bae, Yong-Sik Jung, Young-Mi Jung, Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer, Journal of Korean Academy of Nursing, 2015, 45, 1, 118

    CrossRef

  5. 5
    R.Vierk, J. Bayer, S. Freitag, M. Muhia, K. Kutsche, T. Wolbers, M. Kneussel, T. Sommer, G.M. Rune, Structure-function-behavior relationship in estrogen-induced synaptic plasticity, Hormones and Behavior, 2015,

    CrossRef

  6. 6
    M. Dubois, N. Lapinte, V. Villier, C. Lecointre, V. Roy, M.-C. Tonon, P. Gandolfo, F. Joly, P. Hilber, H. Castel, Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: Role of glucose as adjuvant, Neuropharmacology, 2014, 79, 234

    CrossRef

  7. 7
    L.A.S. Walker, J.A. Berard, H.L. Atkins, M. Bowman, H. Lee, M.S. Freedman, Cognitive change and neuroimaging following immunoablative therapy and hematopoietic stem cell transplantation in multiple sclerosis: A pilot study, Multiple Sclerosis and Related Disorders, 2014, 3, 1, 129

    CrossRef

  8. 8
    Kim Edelstein, Lori J. Bernstein, Cognitive Dysfunction after Chemotherapy For Breast Cancer, Journal of the International Neuropsychological Society, 2014, 20, 04, 351

    CrossRef

  9. 9
    Lori J. Bernstein, Pamela A. Catton, Ian F. Tannock, Intra-individual Variability in Women with Breast Cancer, Journal of the International Neuropsychological Society, 2014, 20, 04, 380

    CrossRef

  10. 10
    Graham J. McDougall, JoAnn S. Oliver, Forrest Scogin, Memory and Cancer: A Review of the Literature, Archives of Psychiatric Nursing, 2014, 28, 3, 180

    CrossRef

  11. 11
    Barbara Collins, Joyce MacKenzie, Giorgio A. Tasca, Carole Scherling, Andra Smith, Persistent Cognitive Changes in Breast Cancer Patients 1 Year Following Completion of Chemotherapy, Journal of the International Neuropsychological Society, 2014, 20, 04, 370

    CrossRef

  12. 12
    Michelle C. Janelsins, Shelli R. Kesler, Tim A. Ahles, Gary R. Morrow, Prevalence, mechanisms, and management of cancer-related cognitive impairment, International Review of Psychiatry, 2014, 26, 1, 102

    CrossRef

  13. 13
    Gaia Schiavon, Ian E Smith, Status of adjuvant endocrine therapy for breast cancer, Breast Cancer Research, 2014, 16, 2, 206

    CrossRef

  14. 14
    Kristy D. Hodgson, Amanda D. Hutchinson, Carlene J. Wilson, Ted Nettelbeck, A meta-analysis of the effects of chemotherapy on cognition in patients with cancer, Cancer Treatment Reviews, 2013, 39, 3, 297

    CrossRef

  15. 15
    Lise Paquet, Barbara Collins, Xinni Song, Anne Chinneck, Marc Bedard, Shailendra Verma, A pilot study of prospective memory functioning in early breast cancer survivors, The Breast, 2013, 22, 4, 455

    CrossRef

  16. 16
    Julie A. Dumas, Jenna Makarewicz, Geoffrey J. Schaubhut, Robert Devins, Kimberly Albert, Kim Dittus, Paul A. Newhouse, Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study, Brain Imaging and Behavior, 2013, 7, 4, 524

    CrossRef

  17. 17
    Erin O’Farrell, Joyce MacKenzie, Barbara Collins, Clearing the Air: A Review of Our Current Understanding of “Chemo Fog”, Current Oncology Reports, 2013, 15, 3, 260

    CrossRef

  18. 18
    Oktay Tacar, Pornsak Sriamornsak, Crispin R. Dass, Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems, Journal of Pharmacy and Pharmacology, 2013, 65, 2
  19. 19
    Brenna C. McDonald, Susan K. Conroy, Dori J. Smith, John D. West, Andrew J. Saykin, Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study, Brain, Behavior, and Immunity, 2013, 30, S117

    CrossRef

  20. 20
    Wendy L. Nelson, Jerry Suls, New Approaches to Understand Cognitive Changes Associated With Chemotherapy for Non-Central Nervous System Tumors, Journal of Pain and Symptom Management, 2013, 46, 5, 707

    CrossRef

  21. 21
    Carole Scherling, Andra Smith, Opening up the Window into “Chemobrain”: A Neuroimaging Review, Sensors, 2013, 13, 3, 3169

    CrossRef

  22. 22
    Barbara Collins, Joyce Mackenzie, Catherine Kyeremanteng, Study of the cognitive effects of chemotherapy: Considerations in selection of a control group, Journal of Clinical and Experimental Neuropsychology, 2013, 35, 4, 435

    CrossRef

  23. 23
    K. L. Pomykala, P. A. Ganz, J. E. Bower, L. Kwan, S. A. Castellon, S. Mallam, I. Cheng, R. Ahn, E. C. Breen, M. R. Irwin, D. H. S. Silverman, The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer, Brain Imaging and Behavior, 2013, 7, 4, 511

    CrossRef

  24. 24
    Jin-Hee Park, Sun Hyoung Bae, A Meta-analysis of Chemotherapy related Cognitive Impairment in Patients with Breast Cancer, Journal of Korean Academy of Nursing, 2012, 42, 5, 644

    CrossRef

  25. 25
    Kelsey L Pomykala, Daniel HS Silverman, Alterations in brain structure and function after chemotherapy for cancer, Future Neurology, 2012, 7, 4, 443

    CrossRef

  26. 26
    Yin Ting Cheung, Earl Hsien-Jie Tan, Alexandre Chan, An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors, Supportive Care in Cancer, 2012, 20, 7, 1361

    CrossRef

  27. You have free access to this content27
    Tim A. Ahles, Brain vulnerability to chemotherapy toxicities, Psycho-Oncology, 2012, 21, 11
  28. 28
    Mei-Ling Chen, Christine Miaskowski, Li-Ni Liu, Shin-Cheh Chen, Changes in perceived attentional function in women following breast cancer surgery, Breast Cancer Research and Treatment, 2012, 131, 2, 599

    CrossRef

  29. 29
    Jeffrey S. Wefel, Sanne B. Schagen, Chemotherapy-Related Cognitive Dysfunction, Current Neurology and Neuroscience Reports, 2012, 12, 3, 267

    CrossRef

  30. 30
    Kristin M. Phillips, Heather S. Jim, Brent J. Small, Christine Laronga, Michael A. Andrykowski, Paul B. Jacobsen, Cognitive functioning after cancer treatment, Cancer, 2012, 118, 7
  31. 31
    Elham Hedayati, Hassan Alinaghizadeh, Anna Schedin, Håkan Nyman, Maria Albertsson, Effects of adjuvant treatment on cognitive function in women with early breast cancer, European Journal of Oncology Nursing, 2012, 16, 3, 315

    CrossRef

  32. 32
    Bok Yae Chung, Hye Sun Byun, Gyung Duck Kim, Kyung Hae Kim, Eun Hee Choi, Experiences of Changes in Cognitive Function for Women treated with Chemotherapy for Breast Cancer, Korean Journal of Women Health Nursing, 2012, 18, 1, 1

    CrossRef

  33. 33
    Bok Yae Chung, Hye Sun Byun, Gyung Duck Kim, Kyung Hae Kim, Eun Hee Choi, Experiences of Changes in Cognitive Function for Women treated with Chemotherapy for Breast Cancer, Korean Journal of Women Health Nursing, 2012, 18, 1, 1

    CrossRef

  34. 34
    Yin Ting Cheung, Wai Keung Chui, Alexandre Chan, Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations, Critical Reviews in Oncology/Hematology, 2012, 83, 1, 99

    CrossRef

  35. 35
    G. Welzel, F. Wenz, Strukturelle Veränderungen der weißen Hirnsubstanz durch Chemotherapie und ihre Korrelation mit kognitiven Beeinträchtigungen, Strahlentherapie und Onkologie, 2012, 188, 6, 523

    CrossRef

  36. 36
    Catherine E. Jansen, Bruce A. Cooper, Marylin J. Dodd, Christine A. Miaskowski, A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients, Supportive Care in Cancer, 2011, 19, 10, 1647

    CrossRef

  37. 37
    B. Collins, Acute and Late Onset Cognitive Dysfunction Associated With Chemotherapy in Women With Breast Cancer, Breast Diseases: A Year Book Quarterly, 2011, 22, 2, 208

    CrossRef

  38. 38
    Michelle C. Janelsins, Sadhna Kohli, Supriya G. Mohile, Kenneth Usuki, Tim A. Ahles, Gary R. Morrow, An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status, Seminars in Oncology, 2011, 38, 3, 431

    CrossRef

  39. 39
    Susan F. Dent, Rania Gaspo, Michelle Kissner, Kathleen I. Pritchard, Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer, Breast Cancer Research and Treatment, 2011, 126, 2, 295

    CrossRef

  40. 40
    Margaret I. Rolfe, Kerrie L. Mengersen, Katharine J. Vearncombe, Brooke Andrew, Geoffrey F. Beadle, Bayesian estimation of extent of recovery for aspects of verbal memory in women undergoing adjuvant chemotherapy treatment for breast cancer, Journal of the Royal Statistical Society: Series C (Applied Statistics), 2011, 60, 5
  41. 41
    Florence Joly, Olivier Rigal, Sabine Noal, Bénédicte Giffard, Cognitive dysfunction and cancer: which consequences in terms of disease management?, Psycho-Oncology, 2011, 20, 12
  42. 42
    Etienne G.C. Brain, Cécile Mertens, Véronique Girre, Frédérique Rousseau, Emmanuel Blot, Sophie Abadie, Lionel Uwer, Emmanuelle Bourbouloux, Isabelle Van Praagh-Doreau, Loic Mourey, Sylvie Kirscher, Brigitte Laguerre, Emmanuelle Fourme, Sylvia Luneau, Jean Genève, Marc Debled, Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial, Critical Reviews in Oncology/Hematology, 2011, 80, 1, 160

    CrossRef

  43. 43
    Lea Ann Ouimet, Angela Stewart, Barbara Collins, Dwayne Schindler, Catherine Bielajew, Investigation of a neuropsychological screen for chemo-fog, Oncology Reviews, 2011, 5, 4, 205

    CrossRef

  44. 44
    Margaret H. Cadden, Nancy S. Koven, Mitchell K. Ross, Neuroprotective Effects of Vitamin D in Multiple Sclerosis, Neuroscience & Medicine, 2011, 02, 03, 198

    CrossRef

  45. 45
    Janette Vardy, Haryana Dhillon, Supportive Oncology, 2011,

    CrossRef

  46. 46
    B. Collins, Cognitive Functioning in Breast Cancer Survivors: A Controlled Comparison, Breast Diseases: A Year Book Quarterly, 2010, 21, 1, 34

    CrossRef

  47. 47
    Maha ELBeltagy, Sarah Mustafa, Jariya Umka, Laura Lyons, Ahmed Salman, Chur-Yoe Gloria Tu, Nikita Bhalla, Geoffrey Bennett, Peter M. Wigmore, Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil, Behavioural Brain Research, 2010, 208, 1, 112

    CrossRef

  48. 48
    Brenna C. McDonald, Susan K. Conroy, Tim A. Ahles, John D. West, Andrew J. Saykin, Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study, Breast Cancer Research and Treatment, 2010, 123, 3, 819

    CrossRef

  49. 49
    Cherise B. Harrington, Jennifer A. Hansen, Michal Moskowitz, Briana L. Todd, Michael Feuerstein, It's Not Over When It's Over: Long-Term Symptoms in Cancer Survivors—A Systematic Review, The International Journal of Psychiatry in Medicine, 2010, 40, 2, 163

    CrossRef

  50. 50
    Andrea Vodermaier, Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments, Women's Health, 2009, 5, 5, 503

    CrossRef

  51. 51
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2009, 18, 8
  52. 52
    KATHARINE JEAN VEARNCOMBE, NANCY A. PACHANA, Impact of health, treatment and psychological factors on cognitive functioning after chemotherapy for early breast cancer, Australian Psychologist, 2009, 44, 4
  53. 53
    KATHARINE J. VEARNCOMBE, MARGARET ROLFE, MARGARET WRIGHT, NANCY A. PACHANA, BROOKE ANDREW, GEOFFREY BEADLE, Predictors of Cognitive Decline After Chemotherapy in Breast Cancer Patients, Journal of the International Neuropsychological Society, 2009, 15, 06, 951

    CrossRef